Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 1
2001 2
2002 2
2003 1
2004 1
2005 3
2006 2
2007 4
2008 8
2009 4
2010 7
2011 7
2012 7
2013 6
2014 7
2015 3
2016 7
2017 8
2018 8
2019 8
2020 12
2021 9
2022 4
2023 4
2024 10
2025 21
2026 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M, Hu W, Cai C, Wu Y, Li J, Dong S. Zhang M, et al. Mater Today Bio. 2022 Feb 21;14:100223. doi: 10.1016/j.mtbio.2022.100223. eCollection 2022 Mar. Mater Today Bio. 2022. PMID: 35243298 Free PMC article. Review.
Currently, available treatment options for inflammatory arthritis include anti-inflammatory medications administered via oral, topical, or intra-articular routes, surgery, and physical rehabilitation. Novel alternative approaches to managing inflammatory arthritis, …
Currently, available treatment options for inflammatory arthritis include anti-inflammatory medications administered via oral, topical, or i …
The critical role of GLP-1 signaling pathways in the pathology of Parkinson's disease and diabetes.
Chen J, Dong X, Lin Y, Lv C. Chen J, et al. Pathol Res Pract. 2025 Jun;270:155985. doi: 10.1016/j.prp.2025.155985. Epub 2025 Apr 22. Pathol Res Pract. 2025. PMID: 40279852 Review.
This review assesses the roles of GLP-1 and its receptor agonists (GLP-1RAs) in the treatment of diabetes and Parkinson's disease, integrating current theories and research. ...Additionally, to enhance GLP-1RAs' efficacy in the nervous system, researchers have introduced …
This review assesses the roles of GLP-1 and its receptor agonists (GLP-1RAs) in the treatment of diabetes and Parkinson's disease, in …
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi S, Nayak AK, Behera A. Padhi S, et al. Biomed Pharmacother. 2020 Nov;131:110708. doi: 10.1016/j.biopha.2020.110708. Epub 2020 Sep 11. Biomed Pharmacother. 2020. PMID: 32927252 Free article. Review.
Given the pathological complexity of the said disease, nanotechnology-based approaches are more enticing as it comes with added advantage of site-specific drug delivery with higher bioavailability and reduced dosage regimen. In the present review artic …
Given the pathological complexity of the said disease, nanotechnology-based approaches are more enticing as it comes with added advan …
Insulin errors and contributing factors affecting people with diabetes in hospital: A scoping review.
Lange Ferreira C, Forbes A, Hashim R, Winkley K. Lange Ferreira C, et al. Int J Nurs Stud. 2025 Jul;167:105074. doi: 10.1016/j.ijnurstu.2025.105074. Epub 2025 Mar 27. Int J Nurs Stud. 2025. PMID: 40239448 Free article.
CONCLUSIONS: The review highlighted considerable heterogeneity in approaches to identifying and classifying insulin errors in the literature. ...SOCIAL MEDIA ABSTRACT: A novel approach to identifying, classifying & exploring insulin e …
CONCLUSIONS: The review highlighted considerable heterogeneity in approaches to identifying and classifying insulin err …
Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications.
Pandey M, Choudhury H, Yi CX, Mun CW, Phing GK, Rou GX, Singh BJKAAJ, Jhee ANA, Chin LK, Kesharwani P, Gorain B, Hussain Z. Pandey M, et al. Curr Drug Targets. 2018;19(15):1782-1800. doi: 10.2174/1389450119666180523092100. Curr Drug Targets. 2018. PMID: 29792143 Review.
Despite facing substantial challenges in developing efficient delivery systems for insulin, vast research studies have been carried out for the development of smart delivery systems to deliver insulin via ocular, buccal, pulmonary, oral, …
Despite facing substantial challenges in developing efficient delivery systems for insulin, vast research studies have …
Recent advances in transdermal insulin delivery technology: A review.
Li H, Shi Y, Ding X, Zhen C, Lin G, Wang F, Tang B, Li X. Li H, et al. Int J Biol Macromol. 2024 Aug;274(Pt 2):133452. doi: 10.1016/j.ijbiomac.2024.133452. Epub 2024 Jun 26. Int J Biol Macromol. 2024. PMID: 38942414 Review.
From the initial singular approach to transdermal drug delivery, there has been a shift toward combining multiple methods to enhance drug permeation efficiency and address the limitations of individual approaches. Technological advancements have …
From the initial singular approach to transdermal drug delivery, there has been a shift toward combining multiple metho …
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.
Volčanšek Š, Koceva A, Jensterle M, Janež A, Muzurović E. Volčanšek Š, et al. Diabetes Ther. 2025 Jun;16(6):1207-1227. doi: 10.1007/s13300-025-01733-8. Epub 2025 May 7. Diabetes Ther. 2025. PMID: 40332747 Free PMC article. Review.
As such, amylin agonists (combined with other members of the incretin class) could represent the elusive drug candidate to address the multi-hormonal dysregulations of diabetes subtypes and qualify as a precision medicine approach that surpasses the long overdue div …
As such, amylin agonists (combined with other members of the incretin class) could represent the elusive drug candidate to address th …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery K. ...Lupu P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilatio …
Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulm …
Future directions in insulin therapy.
Home P. Home P. Metabolism. 2021 Nov;124:154889. doi: 10.1016/j.metabol.2021.154889. Epub 2021 Sep 15. Metabolism. 2021. PMID: 34536491 Review.
Approaches to overcoming these barriers include closed-loop systems and further modification of insulin formulations, but are limited by fundamental underlying difficulties. While clinical studies of oral insulin are in progress, the barriers to succes …
Approaches to overcoming these barriers include closed-loop systems and further modification of insulin formulations, b …
Patch Pumps for Insulin.
Ginsberg BH. Ginsberg BH. J Diabetes Sci Technol. 2019 Jan;13(1):27-33. doi: 10.1177/1932296818786513. Epub 2018 Aug 2. J Diabetes Sci Technol. 2019. PMID: 30070604 Free PMC article. Review.
Newly developed patch pumps are starting to occupy a noticeable fraction of the insulin delivery market. New entrants, using novel technologies, promise accurate, flexible insulin delivery at lower costs. In the section, we review the cur …
Newly developed patch pumps are starting to occupy a noticeable fraction of the insulin delivery market. New entrants, using …
157 results